6-Valent OspA-Based Lyme Disease Vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 6-Valent OspA-Based Lyme Disease Vaccine, covering 2026-03-30 to 2026-03-30. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Learn About the Safety, Tolerability, and Immunogenicity of a Fifth Dose of 6-Valent OspA-Based Lyme Disease Vaccine [Phase 3]